Triaksh Enterprises

Puretrig AQ 5000 IU Injection mimics the action of luteinizing hormone (LH) to stimulate the production of sex hormones in both men and women.

It helps in the normal development of eggs in the ovary and stimulates their release (ovulation), often used in conjunction with other fertility treatments like IVF.

It is used to address low testosterone levels in men by enhancing testosterone and sperm production.
In young boys (typically aged 4-9 years), it can help the testicles descend into the scrotum, provided there is no structural deformity.

Imatero 400 mg is an anti-cancer medication manufactured by Hetero Healthcare Limited. It contains Imatinib Mesylate, a potent targeted therapy belonging to the class of tyrosine kinase inhibitors (TKIs). This drug has fundamentally changed the treatment of certain cancers by specifically targeting abnormal proteins that signal cancer cells to multiply, rather than indiscriminately killing all rapidly dividing cells like traditional chemotherapy.

The primary medical application for Imatero is in the treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL), specifically cases that are Philadelphia chromosome-positive. It is also highly effective for Gastrointestinal Stromal Tumors (GIST), a type of cancer that begins in the digestive tract, as well as rarer conditions such as dermatofibrosarcoma protuberans (DFSP) and hypereosinophilic syndrome (HES).

Veenat 100 mg is an anti-cancer medication manufactured by Natco Pharma Ltd. It contains 100 mg of Imatinib Mesylate, a potent tyrosine kinase inhibitor primarily prescribed to treat various blood and gastrointestinal cancers. The drug works by blocking the action of an abnormal protein (BCR-ABL tyrosine kinase) responsible for signaling the rapid multiplication of cancer cells. By inhibiting this enzyme, Veenat slows or stops the growth of tumors and induces "planned cell death" (apoptosis) in abnormal cells.

This medication is widely used to treat Chronic Myeloid Leukemia (CML), Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GIST). It is also indicated for rarer conditions such as dermatofibrosarcoma protuberans (a type of skin tumor) and hypereosinophilic syndrome.

Mofetyl 500 is an immunosuppressant medication produced by RPG Life Sciences Ltd, containing 500mg of Mycophenolate mofetil. It is primarily used to prevent organ rejection in patients who have undergone kidney, heart, or liver transplants. By weakening the body’s natural defense system, it ensures the immune system does not recognize and attack the new organ as a foreign invader.

In terms of clinical action, Mofetyl 500 works by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH). This process selectively stops the growth and multiplication of white blood cells known as T and B lymphocytes, which are the primary cells responsible for attacking transplanted tissues. It is often prescribed as part of a multi-drug regimen that includes other medications like cyclosporine or corticosteroids to provide comprehensive protection for the graft.

For optimal effectiveness, the medication is typically taken twice daily on an empty stomach—either one hour before or two hours after a meal.

Erlonat 100 mg, manufactured by Natco Pharma Ltd, is an anti-cancer (antineoplastic) medication containing Erlotinib, which belongs to a class of drugs known as tyrosine kinase inhibitors. It is primarily used to treat patients with advanced or metastatic non-small cell lung cancer (NSCLC), particularly those with specific EGFR mutations, and is also prescribed in combination with gemcitabine for metastatic pancreatic cancer. The medication works by binding to and blocking the epidermal growth factor receptor (EGFR) on the surface of cancer cells, thereby disrupting the signaling pathways that cause these cells to multiply and spread.

Lenvat 4 mg is a prescription-based targeted cancer therapy containing Lenvatinib, manufactured by Natco Pharma Ltd. Classified as a tyrosine kinase inhibitor, it functions by blocking specific proteins (enzymes) that cancer cells require to grow and divide. Crucially, it inhibits the formation of new blood vessels—a process called angiogenesis—which effectively cuts off the oxygen and nutrient supply to tumours, thereby slowing or stopping their progression.

This medication is primarily indicated for advanced or progressive cancers that have become resistant to other treatments. Its main uses include treating differentiated thyroid cancer that no longer responds to radioactive iodine therapy, hepatocellular carcinoma (liver cancer) when surgery is not an option, and advanced renal cell carcinoma (kidney cancer), often in combination with other agents. It is also utilised for treating recurrent or advanced endometrial cancer.

Lenvat 4 mg is administered as an oral capsule, typically once daily at a consistent time, with or without food. Patients are advised to swallow the capsule whole and avoid crushing or chewing it to ensure proper absorption.

Nintib 150 mg soft gelatin capsules, manufactured and marketed by Cipla Ltd, contain 150 mg of the active pharmaceutical ingredient Nintedanib. As a member of the tyrosine kinase inhibitor class of medications, it is primarily used to manage chronic, progressive lung conditions such as idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and other chronic fibrosing interstitial lung diseases with a progressive phenotype. In addition to its anti-fibrotic role, it is also indicated for the treatment of certain types of non-small cell lung cancer (NSCLC), specifically adenocarcinoma, often in combination with chemotherapy following the failure of first-line treatments.

The medication works by targeting and blocking specific signaling pathways and enzymes—namely vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) receptors—that contribute to the formation of scar tissue in the lungs. By inhibiting these receptors, Nintib helps slow down the progression of lung scarring and the thickening of lung tissue, which in turn helps preserve lung function and manage symptoms like shortness of breath and chronic dry cough. In cancer treatment, this same inhibitory action disrupts the development of new blood vessels that supply tumors and prevents cancer cells from multiplying.

Lenvatol 10mg is an oral anti-cancer medication manufactured by Cipla Ltd. that contains the active pharmaceutical ingredient Lenvatinib. Classified as a tyrosine kinase inhibitor (TKI), it targets specific proteins on the surface of cancer cells to disrupt the signals they need to grow and multiply. Its unique mechanism also includes an anti-angiogenic effect, which effectively cuts off the supply of blood and nutrients to tumours by preventing the formation of new blood vessels.

This medication is primarily indicated for patients with advanced or metastatic cancers that may not have responded to standard therapies. Its core uses include treating differentiated thyroid cancer that is refractory to radioactive iodine, hepatocellular carcinoma (liver cancer) as a first-line treatment, and advanced renal cell carcinoma (kidney cancer). It is also used to treat endometrial cancer when combined with other immunotherapies.

Administration typically involves taking one 10mg capsule once daily, with or without food, at the same time each day to maintain consistent drug levels.

Lavir 150mg is a prescription antiviral medication produced by Emcure Pharmaceuticals Ltd, containing Lamivudine (150mg) as its primary active component. This drug is classified as a nucleoside reverse transcriptase inhibitor (NRTI), which is specifically used to manage Human Immunodeficiency Virus (HIV) and chronic Hepatitis B (HBV) infections. By blocking the reverse transcriptase enzyme, the medication prevents the virus from replicating and spreading throughout the body, thereby reducing the viral load and supporting a stronger immune system.

In the treatment of HIV, Lavir 150mg is rarely used alone and is typically part of a multi-drug antiretroviral therapy (ART) regimen designed to prevent the progression of the virus to AIDS. When prescribed for chronic Hepatitis B, it helps manage long-term liver infection, reduces potential liver damage, and improves overall liver function. While it effectively controls these conditions, it is important to note that Lavir 150mg is not a cure for HIV or HBV and does not prevent the transmission of these viruses to others.

Patients are generally advised to take the tablet whole with water, either with or without food, though taking it with a meal may improve absorption or reduce stomach discomfort.

Myfortic 360 mg is an immunosuppressive medication manufactured by Novartis that contains the active ingredient mycophenolate sodium. It is primarily indicated for use in combination with other medications, such as cyclosporine and corticosteroids, to prevent organ rejection in adult patients who have received a kidney transplant. By weakening the body's immune system, Myfortic helps ensure that the new organ is not attacked or rejected as a foreign invader.

The medication works by selectively inhibiting an enzyme called inosine monophosphate dehydrogenase (IMPDH), which is crucial for the production of guanosine nucleotides necessary for the growth and multiplication of certain white blood cells known as T- and B-lymphocytes. Because these specific immune cells are primarily responsible for organ rejection, reducing their activity effectively helps the body accept the transplanted kidney.

Cladrim 10 mg Injection by Fresenius Kabi is a prescription anticancer medicine containing cladribine, used primarily in the treatment of certain hematological malignancies, particularly hairy cell leukemia. It works by interfering with the DNA synthesis of abnormal blood cells, leading to reduced growth and elimination of cancerous cells. 
It is primarily indicated for the treatment of active hairy cell leukemia (HCL), a rare type of blood cancer.
Hairy cell leukemia is a kind of blood cancer in which there is excessive production of specific white blood cells (that fight infections) and they resemble hairy-shape when seen under a microscope. Cladrim 10mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.